CRON

2.04

1.49% 0.03

Handel nachbörslich: 2.03 -0.01 -0.49%

Cronos Group Inc (CRON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.01

Offen:

$2.03

24-Stunden-Volumen:

772.58K

Relative Volume:

0.77

Marktkapitalisierung:

$788.00M

Einnahmen:

$87.89M

Nettoeinkommen (Verlust:

$-73.96M

KGV:

-5.3684

EPS:

-0.38

Netto-Cashflow:

$-46.26M

1W Leistung:

+3.55%

1M Leistung:

-6.42%

6M Leistung:

-29.66%

1J Leistung:

+4.08%

1-Tages-Spanne:

$2.01

$2.075

1-Wochen-Bereich:

$2.01

$2.34

52-Wochen-Spanne:

$1.85

$3.14

Cronos Group Inc Stock (CRON) Company Profile

Firmenname

Cronos Group Inc

Sektor

Healthcare (1196)

Branche

Drug Manufacturers - Specialty & Generic (87)

Telefon

(416) 504-0004

Adresse

4491 CONCESSION RD 12, STAYNER, ON

Mitarbeiter

356

Twitter

@cronosgroup

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

CRON's Discussions on Twitter

Vergleichen Sie CRON mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRON	2.04	788.00M	87.89M	-73.96M	-46.26M	-0.38
ZTS	176.42	79.51B	9.15B	2.43B	2.31B	4.92
TAK	13.53	42.89B	30.27B	1.93B	3.45B	0.444
HLN	9.43	42.57B	14.26B	1.55B	0	0.3327
TEVA	16.49	18.51B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.00	15.37B	15.24B	-646.50M	1.88B	1.53

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-11-02	Eingeleitet	Bernstein	Mkt Perform
2022-07-28	Hochstufung	Canaccord Genuity	Hold → Buy
2022-05-11	Hochstufung	CIBC	Neutral → Sector Outperform
2022-03-22	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-27	Hochstufung	Jefferies	Underperform → Hold
2021-11-18	Fortgesetzt	BofA Securities	Underperform
2021-04-28	Fortgesetzt	BofA Securities	Underperform
2021-02-22	Herabstufung	CIBC	Sector Outperform → Neutral
2020-06-24	Hochstufung	Raymond James	Mkt Perform → Outperform
2020-04-27	Herabstufung	Raymond James	Outperform → Mkt Perform
2020-04-14	Herabstufung	Piper Sandler	Overweight → Neutral
2020-04-02	Herabstufung	BofA/Merrill	Buy → Neutral
2020-03-31	Herabstufung	Canaccord Genuity	Hold → Sell
2020-03-04	Hochstufung	MKM Partners	Neutral → Buy
2020-03-03	Herabstufung	Stifel	Buy → Hold
2019-10-18	Hochstufung	Stifel	Hold → Buy
2019-09-20	Eingeleitet	MKM Partners	Neutral
2019-09-05	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2019-08-13	Eingeleitet	Piper Jaffray	Overweight
2019-08-09	Hochstufung	Canaccord Genuity	Sell → Hold
2019-06-28	Eingeleitet	Consumer Edge Research	Equal Weight
2019-06-06	Eingeleitet	Stifel	Hold
2019-06-05	Hochstufung	BofA/Merrill	Underperform → Buy
2019-04-17	Eingeleitet	BofA/Merrill	Underperform
2019-03-27	Herabstufung	Canaccord Genuity	Hold → Sell
2019-02-25	Eingeleitet	Jefferies	Underperform
2019-01-18	Eingeleitet	CIBC	Sector Outperform

Alle ansehen

Cronos Group Inc Aktie (CRON) Neueste Nachrichten

Nov 17, 2024

Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabis - Benzinga

Nov 14, 2024

Roth Capital Lowers Earnings Estimates for Cronos Group - MarketBeat

Nov 14, 2024

Cronos Group (STU:7CI) Long-Term Debt & Capital Lease Obligation : €0.99 Mil (As of Jun. 2024) - GuruFocus.com

Nov 14, 2024

Cronos Group (STU:7CI) Short-Term Capital Lease Obligation : €0.87 Mil (As of Jun. 2024) - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Cronos Group Inc. stock falls Wednesday, underperforms market - MarketWatch

Nov 13, 2024

Cronos: Q3 Earnings Snapshot - MSN

Nov 13, 2024

CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com

Nov 13, 2024

Cronos Group Inc. (NASDAQ:CRON) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Earnings call: Cronos Group sees robust growth with record revenue - Investing.com India

Nov 13, 2024

Earnings call: Cronos Group sees robust growth with record revenue By Investing.com - Investing.com UK

Nov 13, 2024